Drug
Cyproheptadine clinical trials
Also written Periactin.
- studies test it
- 19
- open now
- 1
- in phase 3
- 4
- first study started
- 2010
Keep track of what changes. Save the Cyproheptadine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 1 |
| 2024 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 4
- Phase 4
- 5
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 19
Medical College of Wisconsin (2) · Ciusss de L'Est de l'Île de Montréal (2) · QuantumLeap Healthcare Collaborative (1) · Corey Hawes (1) · University of Miami (1) · Vanderbilt University Medical Center (1) · Shirley Ryan AbilityLab (1) · Indonesia University (1)
Often tested with
Tested in the same studies.
Remdesivir (1) · Imatinib (1) · Dexamethasone (1) · Cenicriviroc (1) · Icatibant (1) · Apremilast (1) · Dornase alfa (1) · Celecoxib (1)
Studies
Open first, then newest update. How each study uses Cyproheptadine is read from its arms, and is right about nine times in ten.
Testing it · 19
- Serotonin Receptor Blockers in Ischemic Mitral RegurgitationRecruitingPhase 2Laval UniversityNCT05469165Written as Cyproheptadine 4 Mg Oral Tablet
- Pediatric Oncology Nutrition Intervention TrialCompletedPhase 2/3Corey HawesNCT06175273Written as Cyproheptadine
- The Use of Cyproheptadine in Pediatric Feeding DisordersCompletedPhase 4University of MiamiNCT06751290Written as Cyproheptadine
- Noninvasive Markers of Functional Nausea in ChildrenCompletedEarly Phase 1Vanderbilt University Medical CenterNCT03593811Written as Cyproheptadine Oral Tablet
- Altering Activation Patterns Post-strokeCompletedNot applicableShirley Ryan AbilityLabNCT02418949Written as Cyproheptadine
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingPhase 2QuantumLeap Healthcare CollaborativeNCT04488081Written as Cyproheptadine
- Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional StatusCompletedNot applicableIndonesia UniversityNCT07006181Written as cyproheptadine hydrochloride
- A Study to Assess the Pharmacokinetic Profile of Prazosin and CyproheptadineCompletedPhase 1Kinnov TherapeuticsNCT06147622Written as Prazosin + cyproheptadine
- Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in CommunityCompletedPhase 4Chulalongkorn UniversityNCT05087381Written as Fluvoxamine, Cyproheptadine
- Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19Status unknownPhase 3Hospital de Clinicas de Porto AlegreNCT04979221Written as Cyproheptadine
- Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19Status unknownPhase 2Ciusss de L'Est de l'Île de MontréalNCT04876573Written as Cyproheptadine Hydrochloride 4 MG
- Cyproheptadine in Severe COVID-19 : A Unblinded Randomized TrialStatus unknownPhase 3Ciusss de L'Est de l'Île de MontréalNCT04820751Written as Cyproheptadine Hydrochloride 4 MG
- Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding DisordersTerminatedPhase 4Medical College of WisconsinNCT02568007Written as Cyproheptadine
- A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal PainTerminatedPhase 2University of MichiganNCT01675050Written as Cyproheptadine
- Mechanisms of Neuromuscular Fatigue Post StrokeCompletedEarly Phase 1Medical College of WisconsinNCT01688570Written as Cyproheptadine
- Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerTerminatedPhase 3University of South FloridaNCT01132547Written as cyproheptadine hydrochloride
- Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord InjuryCompletedNot applicableT. George HornbyNCT01538693Written as Cyproheptadine
- A Study of Combination Therapy in Children With ADHDCompletedPhase 4Douglas SearsNCT01940978Written as Cyproheptadine
- Cyproheptadine as an Appetite StimulantStatus unknownPhase 4St. Justine's HospitalNCT01314989Written as Cyproheptadine
Given in every arm · 3 — Cyproheptadine is usual care beside what is tested
- Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side EffectsCompletedPhase 2Kinnov TherapeuticsNCT04108104Written as Cyproheptadine
- Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerTerminatedPhase 2University of South FloridaNCT00949117Written as cyproheptadine hydrochloride
- Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentCompletedPhase 2University of South FloridaNCT00066248Written as cyproheptadine hydrochloride
Codes
What other systems call Cyproheptadine · ClinicalTrials.gg INT007285
- MeSH (NLM) D003533CyproheptadineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2YHB6175DOCYPROHEPTADINEConfirmed FDA, NLM, Wikidata
- RxNorm 3013Confirmed FDA, Wikidata
- Wikidata Q417884cyproheptadineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61695CyproheptadineOne source FDA
- DrugBank DB00434One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003533 | Cyproheptadine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2YHB6175DO | CYPROHEPTADINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3013 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417884 | cyproheptadine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61695 | Cyproheptadine | One source FDA |
| DrugBank | DB00434 | — | One source Wikidata |
Also registered as cyproheptadine hydrochloride (UNII NJ82J0F8QC · RxNorm 104592).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.